Literature DB >> 25910405

Primary tumors of the facial nerve.

Theodore R McRackan1, Eric P Wilkinson1, Alejandro Rivas2.   

Abstract

This article describes the pathophysiology, diagnosis, treatment, and outcomes of primary tumors of the facial nerve. These tumors include facial nerve schwannomas, geniculate ganglion hemangiomas, glomus facialis, and granular cell tumors. Although these tumors are rare, collected data help to form a consensus with regard to optimal treatment methods.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Facial nerve granular cell tumor; Facial nerve neuroma; Facial nerve paraganglioma; Facial nerve schwannoma; Facial nerve tumors; Facial nerve vascular malformation; Geniculate ganglion hemangioma; Glomus facialis

Mesh:

Year:  2015        PMID: 25910405     DOI: 10.1016/j.otc.2015.02.008

Source DB:  PubMed          Journal:  Otolaryngol Clin North Am        ISSN: 0030-6665            Impact factor:   3.346


  3 in total

Review 1.  Anatomy and Surgical Approach of the Ear and Temporal Bone.

Authors:  Brandon Isaacson
Journal:  Head Neck Pathol       Date:  2018-08-01

2.  Management of non-vestibular schwannomas in adult patients: a systematic review and consensus statement on behalf of the EANS skull base section Part II: Trigeminal and facial nerve schwannomas (CN V, VII).

Authors:  Jarnail Bal; Michael Bruneau; Moncef Berhouma; Jan F Cornelius; Luigi M Cavallo; Roy T Daniel; Sebastien Froelich; Emmanuel Jouanneau; Torstein R Meling; Mahmoud Messerer; Pierre-Hugues Roche; Henry W S Schroeder; Marcos Tatagiba; Idoya Zazpe; Dimitrios Paraskevopoulos
Journal:  Acta Neurochir (Wien)       Date:  2022-01-25       Impact factor: 2.216

3.  Intratemporal Facial Nerve Schwannomas: A Review of 45 Cases in A Single Center.

Authors:  Tsubasa Kitama; Makoto Hosoya; Masaru Noguchi; Takanori Nishiyama; Takeshi Wakabayashi; Marie N Shimanuki; Masaki Yazawa; Yasuhiro Inoue; Jin Kanzaki; Kaoru Ogawa; Naoki Oishi
Journal:  Diagnostics (Basel)       Date:  2022-07-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.